TM7SF2 c.244_245insTTTATCTTCTTCCTGCAC ;(p.L76_A81dup)

Variant ID: 11-64880177-G-GCTTTATCTTCTTCCTGCA

NM_003273.3(TM7SF2):c.244_245insTTTATCTTCTTCCTGCAC;(p.L76_A81dup)

This variant was identified in 1 publication

View GRCh38 version.



Variant-Specific Resource Links:
gnomAD v2.1.1
Mutalizer Name Checker
Google
UCSC Genome Browser
ClinVar
dbSNP

Publications:

bMSAF is a prognostic predictor for advanced hepatocellular carcinoma patients treated with immune checkpoint inhibitor camrelizumab and anti-angiogenic agent apatinib combination therapy.

Clinical And Translational Medicine
Xu, Gehan G; Cui, Liang L; Li, Jin J; Wang, Quanren Q; Li, Pansong P; Xia, Xuefeng X; Yi, Xin X; Guan, Quanlin Q; Xu, Jianming J
Publication Date: 2022-10

Variant appearance in text: TM7SF2: A81_R82insLYLLPA
PubMed Link: 36245284
Variant Present in the following documents:
  • CTM2-12-e1086-s010.xlsx, sheet 5
  • CTM2-12-e1086-s010.xlsx, sheet 4
View BVdb publication page